- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06179992
Study of the Efficacy of GGED: a Cognitive Training App for Eating Disorders.
A Cross-over Randomized-control Study Evaluating the Efficacy of GGED in Reducing Maladaptive Beliefs Related to Eating Disorders.
Study Overview
Detailed Description
There is a digital platform called GGtude, which is composed of different modules, each of them aimed at working with different mental health problems. The goal is to provide an easy-to-use tool as a CBT complement to work on the self-dialogue that relates to the core beliefs associated with the psychological problem in particular. To achieve this target, a cognitive training exercise is performed: different sentences appear in the form of beliefs, and the person must identify and accept those beliefs that are functional, adaptive and positive, dragging them to the lower part of the screen; and reject those that are dysfunctional, maladaptive and negative dragging them to the upper part of the screen.
There are different modules, for example, to work self-esteem, depression, body image or obsessive-compulsive disorder, that have proven their effectiveness.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Valencia, Spain, 46010
- University of Valencia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Ages between 18 and 40.
- Have a dispositive with Internet access.
Exclusion Criteria:
- None.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
The experimental group used the GGED module for 15 days after the first assessment.
|
The intervention will be done through an app named GGED, which is used to work on the dysfunctional beliefs that are associated with eating disorders.
The app is made up of a series of levels comprising the topics that are normally worked on in CBT in relation to eating disorders.
At each level, affirmations in the form of beliefs appear on the screen, and the person must accept them if they are functional, adaptive and positive; or reject them if they are dysfunctional, maladaptive and negative.
Other Names:
|
|
Active Comparator: Control group
The control group used the GGED module for 15 days after the second assessment.
|
The intervention will be done through an app named GGED, which is used to work on the dysfunctional beliefs that are associated with eating disorders.
The app is made up of a series of levels comprising the topics that are normally worked on in CBT in relation to eating disorders.
At each level, affirmations in the form of beliefs appear on the screen, and the person must accept them if they are functional, adaptive and positive; or reject them if they are dysfunctional, maladaptive and negative.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the degree of ascription to dysfunctional beliefs associated with ED.
Time Frame: 15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
Score change in the degree of ascription to dysfunctional beliefs associated with ED measured by the Eating Disorder Beliefs Questionnaire (EDBQ).
It is composed of 32 items that examines core beliefs about weight, physical appearance and eating that are associated with eating disorders.
Items are rated on an analog scale from 0 to 100, being 0 "I do not usually believe this at all" and 100 "I am usually completely convinced that this is true".
Higher scores indicate the person has more degree of ascription to dysfunctional beliefs associated with eating disorders.
|
15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
|
Change in maladaptive body and eating beliefs.
Time Frame: 15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
Score change in maladaptive body and eating beliefs associated with ED measured by Obsessive Beliefs about Body Size and Eating Survey (OBBSES).
It is composed of 57 items, which involve beliefs associated with food, eating, weight and body shape, divided into 5 factors: 1) appearance perfectionism; 2) vulnerability to weight gain; 3) eating control; 4) magical thinking; and, 5) thought control.
People have to indicate in each item their degree of agreement in a Likert scale whit 7 point (1= "desagree very much" and 7 = "agree very much").
Higher scores indicate the person has more maladaptive body and eating beliefs.
|
15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in eating symptomatology.
Time Frame: 15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
Score change in eating symptoms measured by the Eating Disorder Examination Questionnaire (EDE-Q).
It is a 36-item self-report questionnaire with 7-point Likert-type scale ranging from 0 (No day/ No time/ Not at all) to 6 (Every day/ Always/ Completely).
It's composed of attitudinal and behavioral items, using for the present study only the attitudinal items (22 items).
Higher scores indicate the person has greater presence of eating symptomatology.
|
15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
|
Change in body satisfaction.
Time Frame: 15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
Score change in body satisfaction measured by the Body Appreciation Scale-2 (BAS-2).
It is a single-factor questionnaire that evaluates body satisfaction with 10 items on a 5-point Likert scale (1 = Never; 5 = Always).
Higher scores indicate the person has more body satisfaction.
|
15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
|
Change in self-esteem.
Time Frame: 15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
Score change in self-report measures with The Single-Item Self-Esteem Scale (SISE; Robins et al., 2001).
The person has to indicate how the statement "I have high self-esteem" describes him/her on a 9-point scale (1 = "Not very true for me" and 9 = "Very true for me").
Higher scores indicate the person has more self-esteem.
|
15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
|
Change in emotional symptomatology.
Time Frame: 15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
Score change in emotional symptomatology measured by The Depression, Anxiety-Stress Scale (DASS-21).
It is composed of 21 items that evaluate emotional negative symptoms: depression, anxiety and stress.
It has a Likert scale with 4 points (0 = "Did not apply to me at all" and 3 = "Applied to me very much or most of the time").
In this study only the scale of depression was used, composed of 7 items.
Higher scores indicate the person has more emotional symptomatology.
|
15 days, and for experimental group 15 and 30 days later; and for the control group 15 days later
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GVA/2021/162
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eating Disorders
-
Ibn Haldun UniversityCompletedDisordered Eating Behaviors | Eating Pathology | Eating Disorders SymptomsTurkey
-
Ibn Haldun UniversityActive, not recruitingDisordered Eating Behaviors | Eating Pathology | Eating Disorder SymptomsTurkey
-
University of PalermoUniversity of Padova; University of CatanzaroRecruitingEating Disorders | Eating Behavior | Eating Disorder SymptomItaly
-
Axsome Therapeutics, Inc.Enrolling by invitationBinge-Eating DisorderUnited States
-
BioprojetCompleted
-
Ali RezaiActive, not recruiting
-
Axsome Therapeutics, Inc.RecruitingBinge-Eating DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBinge-Eating DisorderUnited States
-
Bezmialem Vakif UniversityMuğla Sıtkı Koçman University; The Scientific and Technological Research Council... and other collaboratorsActive, not recruitingEating Disorders | Eating Behavior | Orthodontic Appliance Complication | Eating HabitTurkey
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
Clinical Trials on GGED mobile app
-
University of ValenciaCompleted
-
The University of Hong KongNorth District Hospital; Queen Mary Hospital, Hong Kong; Pamela Youde Nethersole... and other collaboratorsUnknownSelf Inflicted Injury | Suicide and Self Inflicted InjuryHong Kong
-
University of ValenciaMinistry of Science and InnovationCompleted
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical CenterCompletedPost Traumatic Stress DisorderUnited States
-
Tan Tock Seng HospitalNanyang Technological University; Geriatric Education and Research InstituteEnrolling by invitationCognitive DeclineSingapore
-
Duke UniversityDuke Institute for Health InnovationCompleted
-
Weill Medical College of Cornell UniversityChildren's Health FundRecruitingDepression | Bipolar Disorder | Anxiety Disorders and Symptoms | SymptomsUnited States
-
Arizona State UniversityThe University of Texas Health Science Center at San AntonioCompleted
-
University of ZurichSwitzerland: ETH; Switzerland: MakoraCompleted
-
Aarhus University HospitalRecruitingTic DisordersDenmark